Drugs / GSK3342830
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02751424 | Jun 2016 → Feb 2017 | bacterial infectious disease | GlaxoSmithKline | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK3342830 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02751424 ↗ |
| Route | Intravenous | “will be administered as IV infusion over 1 hour.” NCT02751424 ↗ |